Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
circSLCO1B7 is a circular RNA (circRNA) molecule generated through the back-splicing of exons from the Solute Carrier Organic Anion Transporter Family Member 1B7 (SLCO1B7) gene (GeneCards). It primarily functions as a competitive endogenous RNA (ceRNA), acting as a molecular sponge for microRNAs such as miR-502-3p (PMID: 34154567). By sequestering these microRNAs, circSLCO1B7 prevents the degradation of downstream oncogenic targets like HOXA1, thereby promoting cell proliferation, migration, and invasion in malignancies such as colorectal cancer (PMID: 34154567). Its expression is frequently upregulated in cancerous tissues compared to healthy controls, making it a significant player in tumor progression and metastasis. Although no clinical drugs currently target circSLCO1B7, it is a subject of intense research for RNA-based therapeutic interventions, including antisense oligonucleotides and siRNA-mediated knockdown. Additionally, its stability in biological fluids positions it as a promising non-invasive biomarker for cancer diagnosis and prognosis. Understanding the circSLCO1B7-mediated regulatory axes offers potential for developing precision medicine approaches in oncology.
Acts as a competitive endogenous RNA (ceRNA) by sponging microRNAs (specifically miR-502-3p), which prevents the suppression of oncogenic target genes such as HOXA1, thereby promoting tumor progression (PMID: 34154567).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier organic anion transporter family member 1B7 circular RNA (circSLCO1B7).